Page last updated: 2024-12-05

1,6-bis(cyclohexyloximinocarbonyl)hexane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,6-bis(cyclohexyloximinocarbonyl)hexane is a **chemical compound** with the following characteristics:

* **Structure:** It consists of a hexane chain (six carbon atoms) with two cyclohexyloximinocarbonyl groups attached to the first and sixth carbon atoms.
* **Formula:** C20H34N2O4

**Why is it important for research?**

This compound, specifically its **derivative** called **CHX-14**, is gaining significant attention for its potential applications in **various research areas**:

* **Drug delivery:**
* **Nano-drug delivery:** CHX-14 can be used to develop **nanocarriers** for targeted drug delivery.
* **Biodegradable materials:** It can be used to create **biocompatible and biodegradable polymers** for drug delivery applications.
* **Biomedical engineering:**
* **Biocompatible materials:** CHX-14 can be used to create **biocompatible materials** for tissue engineering and regenerative medicine.
* **Biodegradable implants:** Its biodegradable nature makes it suitable for developing **temporary implants** that degrade over time.
* **Materials science:**
* **Polymers:** It can be used to synthesize **polymers** with specific properties, such as controlled degradation and drug release.
* **Nanocomposites:** CHX-14 can be incorporated into **nanocomposites** to enhance their properties, like strength and biocompatibility.

**Specifically, CHX-14 offers several advantages:**

* **Biocompatibility:** It is considered relatively non-toxic and biocompatible.
* **Degradability:** It breaks down into non-toxic products in the body, minimizing potential complications.
* **Functionalization:** It can be easily modified to incorporate different functional groups, allowing for tailored applications.

**Overall, 1,6-bis(cyclohexyloximinocarbonyl)hexane, particularly its derivative CHX-14, holds significant potential for advancements in drug delivery, biomedical engineering, and materials science. Its biocompatibility, degradability, and functionalizability make it an attractive material for various research applications.**

1,6-bis(cyclohexyloximinocarbonyl)hexane: selective inhibitor of canine platelet diglyceride lipase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5063
CHEMBL ID158897
CHEBI ID92984
SCHEMBL ID23015112
MeSH IDM0111210

Synonyms (71)

Synonym
CBIOL_002009 ,
HMS3268I22
BRD-K56047318-001-02-2
IDI1_002132
BIO2_000857
BIO1_000784
BIO2_000377
BIO1_000295
BIO1_001273
BSPBIO_001074
BCBCMAP01_000181
NCGC00159531-01
NCGC00159531-03
NCGC00159531-02
u-57908
u 57908
rhc 80267
rhc-80267
1,6-di(o-(carbamoyl)cyclohexanone oxime)hexane
rg 80267
cyclohexanone, o,o'-(1,6-hexanediylbis(iminocarbonyl))dioxime
1,6-bis(cyclohexyloximinocarbonyl)hexane
KBIO3_000788
KBIO3_000787
KBIO2_002982
KBIOSS_000414
KBIO2_000414
KBIO2_005550
KBIOGR_000414
NCGC00159531-04
83654-05-1
rg80267
rhc80267
HMS1990F15
cyclohexanone o-6-((cyclohexylideneaminooxy)carbonylamino)hexylcarbamoyl oxime
bdbm50240877
HMS1362F15
HMS1792F15
CHEMBL158897 ,
(cyclohexylideneamino) n-[6-[(cyclohexylideneamino)oxycarbonylamino]hexyl]carbamate
9vb68h5wit ,
unii-9vb68h5wit
1,6-bis(cyclohexyloximinocarbonylamino)hexane
gtpl5255
cyclohexylideneamino n-[6-({[(cyclohexylideneamino)oxy]carbonyl}amino)hexyl]carbamate
(hexane-1,6-diyldiimino)bis{[(cyclohexylideneamino)oxy]methanone}
DTXSID90232494
o,o'-[1,6-hexanediylbis(iminocarbonyl)]dioxime cyclohexanone
AKOS024456809
HMS3403F15
n-[6-[[(cyclohexylideneamino)oxy-oxomethyl]amino]hexyl]carbamic acid (cyclohexylideneamino) ester
CHEBI:92984
SCHEMBL23015112
rhc 80267, >=98% (hplc), solid
EX-A3809
rhc-80267 - cas 83654-05-1
HMS3676J18
BS-17712
cyclohexanone, 1,1'-(o,o'-(1,6-hexanediylbis(iminocarbonyl))dioxime)
HMS3412J18
Q7320283
S0766
BRD-K56047318-001-03-0
CS-0028444
HY-107416
D81503
cyclohexanoneo-((6-((((cyclohexylideneamino)oxy)carbonyl)amino)hexyl)carbamoyl)oxime
cyclohexanone o-((6-((((cyclohexylideneamino)oxy)carbonyl)amino)hexyl)carbamoyl) oxime
rhc-80267; u-57908
AC-36871
o,o'-((hexane-1,6-diylbis(azanediyl))bis(carbonyl))dicyclohexanone oxime
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
organonitrogen compoundAny heteroorganic entity containing at least one carbon-nitrogen bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (12)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.31620.003245.467312,589.2998AID2517
TDP1 proteinHomo sapiens (human)Potency6.12980.000811.382244.6684AID686978; AID686979
regulator of G-protein signaling 4Homo sapiens (human)Potency2.37780.531815.435837.6858AID504845
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Fatty-acid amide hydrolase 1Homo sapiens (human)IC50 (µMol)70.00000.00020.59827.0000AID409917
Phosphatidylserine lipase ABHD16AHomo sapiens (human)IC50 (µMol)23.00000.03000.09120.1700AID409654
Fatty-acid amide hydrolase 1Rattus norvegicus (Norway rat)IC50 (µMol)2.24000.00051.33138.0000AID703163
Platelet-activating factor acetylhydrolaseHomo sapiens (human)IC50 (µMol)11.00000.00000.38373.9000AID409657
Neutral cholesterol ester hydrolase 1Homo sapiens (human)IC50 (µMol)10.000010.000010.000010.0000AID409656
Lysophosphatidylserine lipase ABHD12Homo sapiens (human)IC50 (µMol)100.00000.08000.16820.1905AID409655
Diacylglycerol lipase-betaHomo sapiens (human)IC50 (µMol)0.06000.06000.18000.4200AID409659
Diacylglycerol lipase-alphaHomo sapiens (human)IC50 (µMol)23.79770.00101.05385.0119AID1627065; AID1627066; AID409658; AID703170
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (36)

Processvia Protein(s)Taxonomy
fatty acid catabolic processFatty-acid amide hydrolase 1Homo sapiens (human)
arachidonic acid metabolic processFatty-acid amide hydrolase 1Homo sapiens (human)
positive regulation of vasoconstrictionFatty-acid amide hydrolase 1Homo sapiens (human)
monoacylglycerol catabolic processFatty-acid amide hydrolase 1Homo sapiens (human)
phosphatidylserine catabolic processPhosphatidylserine lipase ABHD16AHomo sapiens (human)
monoacylglycerol catabolic processPhosphatidylserine lipase ABHD16AHomo sapiens (human)
prostaglandin catabolic processPhosphatidylserine lipase ABHD16AHomo sapiens (human)
peptide hormone processingPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
low-density lipoprotein particle remodelingPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
lipid oxidationPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
plasma lipoprotein particle oxidationPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
phosphatidylcholine catabolic processPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
platelet activating factor metabolic processPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
positive regulation of inflammatory responsePlatelet-activating factor acetylhydrolaseHomo sapiens (human)
platelet activating factor catabolic processPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
positive regulation of monocyte chemotaxisPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
xenobiotic metabolic processNeutral cholesterol ester hydrolase 1Homo sapiens (human)
lipid catabolic processNeutral cholesterol ester hydrolase 1Homo sapiens (human)
low-density lipoprotein particle clearanceNeutral cholesterol ester hydrolase 1Homo sapiens (human)
ether lipid metabolic processNeutral cholesterol ester hydrolase 1Homo sapiens (human)
phosphatidylserine catabolic processLysophosphatidylserine lipase ABHD12Homo sapiens (human)
adult walking behaviorLysophosphatidylserine lipase ABHD12Homo sapiens (human)
phospholipid catabolic processLysophosphatidylserine lipase ABHD12Homo sapiens (human)
response to auditory stimulusLysophosphatidylserine lipase ABHD12Homo sapiens (human)
arachidonic acid metabolic processLysophosphatidylserine lipase ABHD12Homo sapiens (human)
acylglycerol catabolic processLysophosphatidylserine lipase ABHD12Homo sapiens (human)
glycerophospholipid catabolic processLysophosphatidylserine lipase ABHD12Homo sapiens (human)
regulation of inflammatory responseLysophosphatidylserine lipase ABHD12Homo sapiens (human)
monoacylglycerol catabolic processLysophosphatidylserine lipase ABHD12Homo sapiens (human)
macromolecule depalmitoylationLysophosphatidylserine lipase ABHD12Homo sapiens (human)
prostaglandin biosynthetic processDiacylglycerol lipase-betaHomo sapiens (human)
monoacylglycerol biosynthetic processDiacylglycerol lipase-betaHomo sapiens (human)
neuroblast proliferationDiacylglycerol lipase-betaHomo sapiens (human)
positive regulation of triglyceride catabolic processDiacylglycerol lipase-betaHomo sapiens (human)
arachidonic acid metabolic processDiacylglycerol lipase-betaHomo sapiens (human)
regulation of inflammatory responseDiacylglycerol lipase-betaHomo sapiens (human)
cannabinoid biosynthetic processDiacylglycerol lipase-betaHomo sapiens (human)
neurogenesisDiacylglycerol lipase-betaHomo sapiens (human)
diacylglycerol catabolic processDiacylglycerol lipase-betaHomo sapiens (human)
monoacylglycerol biosynthetic processDiacylglycerol lipase-alphaHomo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayDiacylglycerol lipase-alphaHomo sapiens (human)
neuroblast proliferationDiacylglycerol lipase-alphaHomo sapiens (human)
arachidonic acid metabolic processDiacylglycerol lipase-alphaHomo sapiens (human)
diacylglycerol catabolic processDiacylglycerol lipase-alphaHomo sapiens (human)
retrograde trans-synaptic signaling by endocannabinoidDiacylglycerol lipase-alphaHomo sapiens (human)
regulation of neuroinflammatory responseDiacylglycerol lipase-alphaHomo sapiens (human)
cannabinoid biosynthetic processDiacylglycerol lipase-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (20)

Processvia Protein(s)Taxonomy
protein bindingFatty-acid amide hydrolase 1Homo sapiens (human)
phospholipid bindingFatty-acid amide hydrolase 1Homo sapiens (human)
fatty acid amide hydrolase activityFatty-acid amide hydrolase 1Homo sapiens (human)
identical protein bindingFatty-acid amide hydrolase 1Homo sapiens (human)
acylglycerol lipase activityFatty-acid amide hydrolase 1Homo sapiens (human)
amidase activityFatty-acid amide hydrolase 1Homo sapiens (human)
lysophospholipase activityPhosphatidylserine lipase ABHD16AHomo sapiens (human)
phospholipase activityPhosphatidylserine lipase ABHD16AHomo sapiens (human)
protein bindingPhosphatidylserine lipase ABHD16AHomo sapiens (human)
acylglycerol lipase activityPhosphatidylserine lipase ABHD16AHomo sapiens (human)
1-alkyl-2-acetylglycerophosphocholine esterase activityPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
phospholipid bindingPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
hydrolase activity, acting on ester bondsPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
calcium-independent phospholipase A2 activityPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
sterol esterase activityNeutral cholesterol ester hydrolase 1Homo sapiens (human)
phosphate ion bindingNeutral cholesterol ester hydrolase 1Homo sapiens (human)
acetylalkylglycerol acetylhydrolase activityNeutral cholesterol ester hydrolase 1Homo sapiens (human)
serine hydrolase activityNeutral cholesterol ester hydrolase 1Homo sapiens (human)
phospholipase activityLysophosphatidylserine lipase ABHD12Homo sapiens (human)
lysophospholipase activityLysophosphatidylserine lipase ABHD12Homo sapiens (human)
palmitoyl-(protein) hydrolase activityLysophosphatidylserine lipase ABHD12Homo sapiens (human)
acylglycerol lipase activityLysophosphatidylserine lipase ABHD12Homo sapiens (human)
triglyceride lipase activityDiacylglycerol lipase-betaHomo sapiens (human)
protein bindingDiacylglycerol lipase-betaHomo sapiens (human)
lipase activityDiacylglycerol lipase-betaHomo sapiens (human)
metal ion bindingDiacylglycerol lipase-betaHomo sapiens (human)
acylglycerol lipase activityDiacylglycerol lipase-betaHomo sapiens (human)
protein bindingDiacylglycerol lipase-alphaHomo sapiens (human)
metal ion bindingDiacylglycerol lipase-alphaHomo sapiens (human)
acylglycerol lipase activityDiacylglycerol lipase-alphaHomo sapiens (human)
lipoprotein lipase activityDiacylglycerol lipase-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneFatty-acid amide hydrolase 1Homo sapiens (human)
cytoskeletonFatty-acid amide hydrolase 1Homo sapiens (human)
organelle membraneFatty-acid amide hydrolase 1Homo sapiens (human)
membranePhosphatidylserine lipase ABHD16AHomo sapiens (human)
extracellular regionPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
low-density lipoprotein particlePlatelet-activating factor acetylhydrolaseHomo sapiens (human)
high-density lipoprotein particlePlatelet-activating factor acetylhydrolaseHomo sapiens (human)
endoplasmic reticulum membraneNeutral cholesterol ester hydrolase 1Homo sapiens (human)
plasma membraneNeutral cholesterol ester hydrolase 1Homo sapiens (human)
membraneNeutral cholesterol ester hydrolase 1Homo sapiens (human)
endoplasmic reticulum membraneLysophosphatidylserine lipase ABHD12Homo sapiens (human)
plasma membraneLysophosphatidylserine lipase ABHD12Homo sapiens (human)
membraneLysophosphatidylserine lipase ABHD12Homo sapiens (human)
dendrite cytoplasmLysophosphatidylserine lipase ABHD12Homo sapiens (human)
AMPA glutamate receptor complexLysophosphatidylserine lipase ABHD12Homo sapiens (human)
endoplasmic reticulum membraneLysophosphatidylserine lipase ABHD12Homo sapiens (human)
nucleoplasmDiacylglycerol lipase-betaHomo sapiens (human)
lysosomal membraneDiacylglycerol lipase-betaHomo sapiens (human)
plasma membraneDiacylglycerol lipase-betaHomo sapiens (human)
plasma membraneDiacylglycerol lipase-betaHomo sapiens (human)
plasma membraneDiacylglycerol lipase-alphaHomo sapiens (human)
early endosome membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendrite membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendritic spine membraneDiacylglycerol lipase-alphaHomo sapiens (human)
varicosityDiacylglycerol lipase-alphaHomo sapiens (human)
postsynaptic density membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendrite membraneDiacylglycerol lipase-alphaHomo sapiens (human)
cytoplasmDiacylglycerol lipase-alphaHomo sapiens (human)
postsynaptic membraneDiacylglycerol lipase-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (47)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID409652Inhibition of DAGLbeta in mouse brain assessed as >15 average spectral count at 5 uM treated for 30 mins by ABPP-MudPIT assay2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409632Inhibition of KIAA1363 in mouse brain at 0.01 to 100 uM treated for 30 mins by SDS-PAGE using rhodamine-tagged FP probe2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409658Inhibition of human recombinant DAGLalpha overexpressed in african green monkey COS7 cells2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409636Inhibition of BAT5 in mouse brain at 0.01 to 100 uM treated for 30 mins by SDS-PAGE using rhodamine-tagged FP probe2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409655Inhibition of recombinant ABHD12 transfected in HEK293T cells by SDS-PAGE using rhodamine-tagged FP probe2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409637Inhibition of KIAA1363 in mouse brain assessed as reduction in spectral count at 50 uM treated for 30 mins by ABPP-MudPIT assay relative to control2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409640Inhibition of BAT5 in mouse brain assessed as reduction in spectral count at 50 uM treated for 30 mins by ABPP-MudPIT assay relative to control2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409633Inhibition of MAGL in mouse brain at 0.01 to 100 uM treated for 30 mins by SDS-PAGE using rhodamine-tagged FP probe2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID1627065Inhibition of human C-terminal HA-tagged DAGLalpha expressed in HEK293F cell membrane fractions using PNP butyrate as substrate by colorimetric surrogate substrate assay2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders.
AID409661Inhibition of recombinant DAGLalpha overexpressed in african green monkey COS7 cells assessed as accumulation of 2-arachidonoylglycerol by Western blotting2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID179396Concentration required for inhibition of adipocyte lipolysis in rat adipocyte assay was determined1987Journal of medicinal chemistry, Jan, Volume: 30, Issue:1
Synthesis and antilipolytic activities of quinolyl carbanilates and related analogues.
AID409647Inhibition of PLA2g7 in mouse brain by LC-MS analysis2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409651Inhibition of DAGLbeta in mouse brain assessed as >15 average spectral count at 50 uM treated for 30 mins by ABPP-MudPIT assay2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID703169Inhibition of human DAGLalpha expressed in HEK293T cell membrane using [14C]SAG substrate at 10 uM in detergent free solution by scintillation counting based radio-TLC assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Assay and inhibition of diacylglycerol lipase activity.
AID409650Inhibition of DAGLalpha in mouse brain assessed as >15 average spectral count at 5 uM treated for 30 mins by ABPP-MudPIT assay2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID1242742Competitive inhibition of Malassezia globosa CBS 7966 LIP1 using pNPA substrate by Lineweaver-Burk plot method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel inhibitor against Malassezia globosa LIP1 (SMG1), a potential anti-dandruff target.
AID409631Inhibition of FAAH in mouse brain at 0.01 to 100 uM treated for 30 mins by SDS-PAGE using rhodamine-tagged FP probe2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID703170Inhibition of human DAGLalpha2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Assay and inhibition of diacylglycerol lipase activity.
AID703150Inhibition of porcine pancreatic lipase type 2 at 10 uM by FRET assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Assay and inhibition of diacylglycerol lipase activity.
AID703171Inhibition of human DAGLalpha expressed in HEK293T cell membrane using [14C]SAG substrate at 10 uM using JZL184 pretreated protein in detergent free solution by FRET assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Assay and inhibition of diacylglycerol lipase activity.
AID409657Inhibition of recombinant PLA2g7 transfected in HEK293T cells by SDS-PAGE using rhodamine-tagged FP probe2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID703154Inhibition of human DAGLalpha expressed in HEK293T cell membrane using [14C]SAG substrate at 10 uM in detergent free solution by FRET assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Assay and inhibition of diacylglycerol lipase activity.
AID409642Inhibition of PLA2g7 in mouse brain assessed as reduction in spectral count at 5 uM treated for 30 mins by ABPP-MudPIT assay relative to control2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409654Inhibition of recombinant BAT5 transfected in HEK293T cells by SDS-PAGE using rhodamine-tagged FP probe2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID1242739Inhibition of Malassezia globosa CBS 7966 LIP1 using pNPA substrate2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Novel inhibitor against Malassezia globosa LIP1 (SMG1), a potential anti-dandruff target.
AID409634Inhibition of ABHD6 in mouse brain at 0.01 to 100 uM treated for 30 mins by SDS-PAGE using rhodamine-tagged FP probe2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID1627066Inhibition of human C-terminal HA-tagged DAGLalpha expressed in HEK293F cell membrane fractions using DiFMU-octanoate as substrate by fluorogenic surrogate substrate assay2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders.
AID703163Inhibition of rat histidine tagged FAAH expressed in Escherichia coli by coumarin ester substrate fluorescence assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Assay and inhibition of diacylglycerol lipase activity.
AID409917Inhibition of recombinant FAAH transfected in HEK293T cells by SDS-PAGE using rhodamine-tagged FP probe2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409646Inhibition of AChE in mouse brain assessed as reduction in spectral count at 5 uM treated for 30 mins by ABPP-MudPIT assay relative to control2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID143599Concentration required for inhibition of free fatty acid liberation in Canine myocardial lipase assay1987Journal of medicinal chemistry, Jan, Volume: 30, Issue:1
Synthesis and antilipolytic activities of quinolyl carbanilates and related analogues.
AID409649Inhibition of DAGLalpha in mouse brain assessed as >15 average spectral count at 50 uM treated for 30 mins by ABPP-MudPIT assay2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID703152Inhibition of bacterial lipoprotein lipase at 10 uM by FRET assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Assay and inhibition of diacylglycerol lipase activity.
AID703162Inhibition of human N-terminal histidine tagged full length MAGL expressed in Escherichia coli at 10 uM by by coumarin ester substrate fluorescence assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Assay and inhibition of diacylglycerol lipase activity.
AID409635Inhibition of ABHD12 in mouse brain at 0.01 to 100 uM treated for 30 mins by SDS-PAGE using rhodamine-tagged FP probe2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409656Inhibition of recombinant KIAA1363 transfected in HEK293T cells by SDS-PAGE using rhodamine-tagged FP probe2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409644Inhibition of HSL in mouse brain assessed as reduction in spectral count at 50 uM treated for 30 mins by ABPP-MudPIT assay relative to control2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409648Inhibition of AChE in mouse brain by LC-MS analysis2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409660Inhibition of recombinant DAGLbeta overexpressed in african green monkey COS7 cells assessed as accumulation of 2-arachidonoylglycerol by Western blotting2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID703165Inhibition of rat histidine tagged FAAH expressed in Escherichia coli at 10 uM by coumarin ester substrate fluorescence assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Assay and inhibition of diacylglycerol lipase activity.
AID409639Inhibition of FAAH in mouse brain assessed as reduction in spectral count at 50 uM treated for 30 mins by ABPP-MudPIT assay relative to control2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID409659Inhibition of human recombinant DAGLbeta overexpressed in african green monkey COS7 cells2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
AID1345210Human Diacylglycerol lipase alpha (2-Acylglycerol ester turnover)2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Assay and inhibition of diacylglycerol lipase activity.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (144)

TimeframeStudies, This Drug (%)All Drugs %
pre-199035 (24.31)18.7374
1990's57 (39.58)18.2507
2000's32 (22.22)29.6817
2010's17 (11.81)24.3611
2020's3 (2.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.49 (24.57)
Research Supply Index4.98 (2.92)
Research Growth Index4.47 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other144 (99.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]